SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Nuria Novoa

Nuria Novoa

Hospital Universitario Puerta de Hierro, Madrid

Prof. Nuria M. Novoa is Head of the Department of General Thoracic Surgery at Hospital Universitario Puerta de Hierro-Majadahonda in Madrid, Spain, and Associate Professor of Thoracic Surgery at the University of Salamanca. Her research centres on the surgical management of non-small cell lung cancer, preoperative risk estimation, postoperative outcomes and quality of life, including multicentre European work on neoadjuvant immunochemotherapy for resectable lung cancer. She served as President of the European Society of Thoracic Surgeons (ESTS) for the 2024-2025 term and is a frequent speaker at major international thoracic surgery and lung cancer congresses.

Connect

Nuria Novoa

Featured in

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates